论文部分内容阅读
目的探讨可回收食管支架在治疗贲门失驰缓症的临床价值。方法 2007年1月~2010年3月,对22例贲门失弛缓症患者采用内镜直视下置入可回收支架并比较支架置入前、支架取出后3个月患者症状评分、食管最大宽度(MWE)、下食管括约肌静息压(LESP),并对患者进行长期随访。结果 1症状评分(8.12±1.88)VS(1.67±0.51),P<0.01。2食管最大宽度为(3.35±0.23)VS(1.78±0.34),P<0.05。3LESP为(41.36±8.24)VS(11.86±2.76),P<0.01。4术后并发症发生率:疼痛57.6%(15/26),支架脱落及移位15.4%(4/26),烧心等3.8%(1/26)。5随访3、6、12、24个月仅有0、0、1(3.8%)、2(7.6%)例患者复发。结论支架置入治疗贲门失弛缓症并发症少,近期及远期疗效满意,是一种简单可行、安全有效的治疗方法。
Objective To investigate the clinical value of recoverable esophageal stent in the treatment of cardia dementia. Methods From January 2007 to March 2010, 22 patients with achalasia underwent endoscopic retrograde placement of recoverable stents and compared their symptom score, maximal esophageal width (MWE), lower esophageal sphincter resting pressure (LESP), and long-term follow-up of patients. Results 1 Symptom Score (8.12 ± 1.88) VS (1.67 ± 0.51), P <0.01.2 The maximum esophageal width was (3.35 ± 0.23) VS (1.78 ± 0.34), P <0.05.3 LESP was (41.36 ± 8.24) VS 11.86 ± 2.76), P <0.01.4 The incidence of postoperative complications: pain 57.6% (15/26), stenting 15.4% (4/26), heartburn 3.8% (1/26). There were only 0, 0 and 1 (3.8%) in 3, 6, 12 and 24 months follow-up, and 2 (7.6%) in 5 cases. Conclusion Stenting is a simple, feasible and safe method for the treatment of achalasia with fewer complications and satisfactory short-term and long-term results.